Measuring a Cancer Drug’s Effectiveness
From the Editor-in-Chief of Cancer Today Magazine:
Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?
Home > Practical Knowledge > Measuring a Cancer Drug’s Effectiveness
From the Editor-in-Chief of Cancer Today Magazine:
Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?
In every issue, Cancer Today offers information and inspiration as readers face the challenges of diagnosis, treatment, survivorship, or caregiving. Cancer Today subscriptions are free to cancer patients, survivors, caregivers, and others in the United States.
Subscribe Today